Which of the following is/are growth hormone receptor antagonist(s) indicated in the treatment of Acromegaly? 1. Octreotide 2. Lanreotide 3. Pasireotide 4. Pegvisomant Select the correct answer using the code given below:
4 only
Pegvisomant is a true growth hormone receptor antagonist used in acromegaly. Octreotide, Lanreotide, and Pasireotide are somatostatin receptor analogues that suppress GH secretion but do not block the GH receptor itself. Hence only statement 4 is correct.
With regard to the treatment of phaeochromocytoma, beta-blocker should never be given before alpha-blocker because it may cause:
Liquorice misuse, by inhibiting 11 beta-hydroxysteroid dehydrogenase type 2 enzyme, can cause a condition which resembles the clinical features of:
Which of the following statements regarding Autoimmune Polyendocrine Syndromes (APS) is/are correct?
1. APS Type 1 is more common than APS Type 2.
2. APS Type 1 is inherited as an autosomal recessive condition.
3. APS Type 2 is inherited as an autosomal dominant condition.
Select the correct answer using the code given below:
| List I (disease) | List II (signs) |
| A. Conn syndrome | 1. Anosmia |
| B. Turner syndrome | 2. Tetany |
| C. Kallman syndrome | 3. Lymphoedema |
| D. Cushing syndrome | 4. Avascular necrosis of hip |